Guggenheim Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
61,050
+6,022
| +11% | +$166K | 0.01% | 701 |
|
|
2025
Q1 | $1.56M | Buy |
55,028
+1,395
| +3% | +$39.5K | 0.01% | 710 |
|
|
2024
Q4 | $2.23M | Sell |
53,633
-91,055
| -63% | -$3.79M | 0.02% | 617 |
|
|
2024
Q3 | $9.67M | Buy |
144,688
+13,157
| +10% | +$879K | 0.07% | 318 |
|
|
2024
Q2 | $15.6M | Sell |
131,531
-7,188
| -5% | -$854K | 0.11% | 176 |
|
|
2024
Q1 | $14.8M | Sell |
138,719
-20,790
| -13% | -$2.22M | 0.1% | 194 |
|
|
2023
Q4 | $15.9M | Buy |
159,509
+12,632
| +9% | +$1.26M | 0.12% | 176 |
|
|
2023
Q3 | $15.2M | Buy |
146,877
+5,122
| +4% | +$529K | 0.13% | 170 |
|
|
2023
Q2 | $17.2M | Buy |
141,755
+14,669
| +12% | +$1.78M | 0.14% | 147 |
|
|
2023
Q1 | $19.5M | Buy |
127,086
+6,056
| +5% | +$930K | 0.16% | 126 |
|
|
2022
Q4 | $21.7M | Sell |
121,030
-1,368
| -1% | -$246K | 0.19% | 111 |
|
|
2022
Q3 | $14.5M | Sell |
122,398
-11,762
| -9% | -$1.39M | 0.13% | 176 |
|
|
2022
Q2 | $19.2M | Sell |
134,160
-3,540
| -3% | -$506K | 0.15% | 150 |
|
|
2022
Q1 | $23.7M | Sell |
137,700
-29,589
| -18% | -$5.1M | 0.14% | 158 |
|
|
2021
Q4 | $42.5M | Buy |
167,289
+41,269
| +33% | +$10.5M | 0.22% | 83 |
|
|
2021
Q3 | $48.5M | Sell |
126,020
-4,150
| -3% | -$1.6M | 0.29% | 55 |
|
|
2021
Q2 | $30.6M | Buy |
130,170
+2,994
| +2% | +$704K | 0.18% | 96 |
|
|
2021
Q1 | $16.7M | Sell |
127,176
-20,184
| -14% | -$2.64M | 0.11% | 208 |
|
|
2020
Q4 | $15.4M | Sell |
147,360
-26,563
| -15% | -$2.78M | 0.1% | 203 |
|
|
2020
Q3 | $12.3M | Buy |
173,923
+50,270
| +41% | +$3.56M | 0.09% | 222 |
|
|
2020
Q2 | $7.94M | Buy |
+123,653
| New | +$7.94M | 0.06% | 345 |
|